Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.83 USD
204.40 M USD
1.79 B USD
174.98 M
About ROHTO PHARMACEUTICAL CO
Sector
Industry
Headquarters
Osaka
Website
Founded
1899
ISIN
JP3982400008
FIGI
BBG000CVQ7C0
Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. Its products include eye drops, contact lens care, dermal medicines, skin care, internal medicines, cold remedies, test kits, and denture cleansers. Its operations are carried out through the following segments: Japan, America, Europe, Asia, and Others. The company was founded by Anmin Yamada on February 22, 1899 and is headquartered in Osaka, Japan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RPHCF is 21.54 USD — it has increased by 5.13% in the past 24 hours. Watch Rohto Pharmaceutical Co. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Rohto Pharmaceutical Co. stocks are traded under the ticker RPHCF.
We've gathered analysts' opinions on Rohto Pharmaceutical Co. future price: according to them, RPHCF price has a max estimate of 29.73 USD and a min estimate of 15.84 USD. Watch RPHCF chart and read a more detailed Rohto Pharmaceutical Co. stock forecast: see what analysts think of Rohto Pharmaceutical Co. and suggest that you do with its stocks.
RPHCF reached its all-time high on Dec 23, 2022 with the price of 35.67 USD, and its all-time low was 16.23 USD and was reached on Jan 9, 2023. View more price dynamics on RPHCF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
RPHCF stock is 4.88% volatile and has beta coefficient of 0.54. Track Rohto Pharmaceutical Co. stock price on the chart and check out the list of the most volatile stocks — is Rohto Pharmaceutical Co. there?
Today Rohto Pharmaceutical Co. has the market capitalization of 4.05 B, it has increased by 5.87% over the last week.
Yes, you can track Rohto Pharmaceutical Co. financials in yearly and quarterly reports right on TradingView.
Rohto Pharmaceutical Co. is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
RPHCF earnings for the last quarter are 0.14 USD per share, whereas the estimation was 0.24 USD resulting in a −44.51% surprise. The estimated earnings for the next quarter are 0.32 USD per share. See more details about Rohto Pharmaceutical Co. earnings.
Rohto Pharmaceutical Co. revenue for the last quarter amounts to 492.04 M USD, despite the estimated figure of 494.10 M USD. In the next quarter, revenue is expected to reach 577.46 M USD.
RPHCF net income for the last quarter is 30.87 M USD, while the quarter before that showed 52.70 M USD of net income which accounts for −41.42% change. Track more Rohto Pharmaceutical Co. financial stats to get the full picture.
Rohto Pharmaceutical Co. dividend yield was 0.91% in 2023, and payout ratio reached 19.91%. The year before the numbers were 0.79% and 19.03% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 22, 2024, the company has 7.26 K employees. See our rating of the largest employees — is Rohto Pharmaceutical Co. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Rohto Pharmaceutical Co. EBITDA is 317.63 M USD, and current EBITDA margin is 18.04%. See more stats in Rohto Pharmaceutical Co. financial statements.
Like other stocks, RPHCF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Rohto Pharmaceutical Co. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Rohto Pharmaceutical Co. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Rohto Pharmaceutical Co. stock shows the neutral signal. See more of Rohto Pharmaceutical Co. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.